VIMGF
Vimian Group AB (publ)Healthcare · $1.5B market cap
Is VIMGF undervalued?
Share price
$2.77
as of Oct 21, 2026
Fair value
$3.23
Sticker Price
Payback Price
$1.29
buy price
VIMGF is Undervalued: at $2.77 it trades 14% below its fair value of $3.23. Its buy price (Payback Price) is $1.29, 53% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 15% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
3 of 5 clear the 10% bar. What are the Big Five?
Follow VIMGF
Get notified when it reaches its buy price of $1.29. Free.
Create a free accountQuestions about VIMGF
What is VIMGF's fair value?
$3.23 as of Oct 21, 2026, worked out with the Free Cash Flow. Sales grew 15% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
At what price would VIMGF be a buy?
At or below its buy price of $1.29, a 60% margin of safety below its fair value.
Is VIMGF undervalued right now?
VIMGF is Undervalued: at $2.77 it trades 14% below its fair value and 114% above its buy price.
How can I check VIMGF's value myself?
Use the free Sticker Price calculator, already filled with VIMGF's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Medical - Diagnostics & Research
About Vimian Group AB (publ)
Vimian Group AB (publ) is an international enterprise focused on the animal health sector, organized into four distinct divisions: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers a range of proprietary diagnostic tools and treatments under its Nextmune brand, providing both prescription and non-prescription options for the preventive care and management of chronic conditions in companion animals. Through its Indical Bioscience brand, Vimian delivers sophisticated molecular and immunodiagnostic solutions for laboratories, specifically targeting veterinary applications for both livestock and companion animal health markets. Moreover, its VetFamily brand operates a membership-based platform that provides veterinary clinics with procurement services, tech-enabled operations including online marketing, education, and HR support, as well as a professional community. The company also supplies orthopedic implants to veterinarians and universities through its Movora brand. Established in 2020, Vimian Group is based in Stockholm, Sweden.
Medical - Diagnostics & Research
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 21, 2026. How the Payback Price works